The RESET-HA Study is a clinical research study for people who experience joint pain due to hemophilia. The study is evaluating an oral non-opioid investigational drug designed to be taken once a day to see if it may potentially help relieve joint pain and improve physical function in people with hemophilic arthropathy (HA).
Are 12 to 75 years of age (inclusive)
Have been diagnosed with hemophilia A or B
Have chronic pain in one or more joints
Do not take opioid medication more than four days a week
If you are interested in learning more about taking part in the RESET-HA study, please speak to a member of our study staff by contacting a study location near you.